Upcoming Seminar:

Date to be Announced

Speaker to be Announced

-

-

 




 

Previous Seminars:

2017

  • 3/23 Simon Leedham, University of Oxford "Morphogen Signaling in Intestinal Inflammation and Carcinogenesis"
  • 3/10 Kristin R. Swanson, Mayo Clinic "Patient-specific Mathematical Neuro-oncology: Every Patient Deserves Their Own Equation"
  • 3/7 Michalina Janiszewska, Dana-Farber Cancer Institute "Intratumor Heterogeneity, Topology and Therapeutic Resistance

  • 1/12 Elsa Flores, Moffitt Cancer Center "Title to be announced"

2016

  • 12/17 Leah Jonston, USF “Inference for Mechanistic Biological Models

  • 12/1 Claudia Fischbach, Cornell PSOC "Engineering Approaches to Study the Role of ECM Dynamics in the Tumor Microenvironment"

  • 11/14 Sebastien Benzekry, University of Bordeaux "A Few Contributions of Quantitative Modeling in Oncology: Combines Experimental and Modeling Studies"
  • 11/3 Abbas Shirinifard, St. Jude Children's Research Hospital "An Individualized Predictive 3D Model of Tumor Response to Topotecan for a Patient-Derived Orthotopic Xenograft Model of Pediatric Neuroblastoma"
  • 6/17 Andrew Dhawan “Collateral Sensitivity and Fitness Landscapes in ALK-Positive Lung Cancer

  • 5/26 Behnaz Seyfi, UCF “Patient-Specific Model of Human Lung Deformation Using Spatially Dependent Elastic Property

  • 5/24 Arijit Chakravarty, Takeda “The Evolutionary Biology of Cancer: Implications for the Intelligent Design of Anticancer Agents

  • 5/19 John Mulinax, Moffitt “Isolation, Expansion and Characterization of the Immune Infiltrate in Soft Tissue Sarcoma

  • 5/12 Richard Bertram, Florida St “Marrying Mathematical and Experimental Biology

  • 5/5 Tobjorn Lundh, Gothenburg “Competition-Collaboration among Cancer Cell strains

  • 4/21 Andrii Rozhok, UC Denver “Toward an evolutionary model of cancer: insights from in silico modeling and recent experimental findings in the hematopoietic system

  • 4/7 Chris Heery, NCI “Early Stage Immunotherapy Clinical Trials: Correlative Studies to Inform Biologic Understanding

  • 3/29 Marc Ryser, Duke “Stage O Cancer: To treat, or Not to Treat (Right Away), That is the Question

  • 3/17 Ambers Smith, St. Jude “Identifying immune mechanisms of influenzapneumococcal coinfection with model driven experiments

  • 3/3 Eric Stahlberg, NCI “High performance computing in cancer

  • 2/25 Heiko Enderling, Moffitt “Quantitative personalized medicine

  • 1/22 Philip Maini, Oxford “Problem-driven quantitative approaches in cancer

  • 1/21 Sunjune Kim, Moffitt “The immune mechanisms of abscopal effect

2015

  • 12/10 Bonnie Sloane, Wayne State “Spatio-Temporal Modeling and Live-Cell Imaging of 3D Tumor Microenvironment in TAME Chambers

  • 1/7 Hatem Soliman, Moffitt “Breast cancer and immunotherapy

  • 11/19 Benedict Bauer, Max Planck Institute, Ploen “Population Dynamics with Epistatic Interactions and its Applications to Mathematical Models of Cancer

  • 11/5 Vincent Cannataro, U Florida “Quantifying the Burden of Somatic Evolution in the Context of Cancer and Aging

  • 10/22 Etienne Baratchart, “Data-driven modeling of metastatic initiation and tumour-tumour spatial interactions

  • 9/1 Daniel Abate Daga, Moffitt “CAR-T cell therapies. A model

  • 8/17 Jana Gevertz , College of New Jersey “Immunostimulatory Oncolytic Virotherapy with Dendritic Cell Injections: Treatment Dynamics and Optimal Combinations

  • 8/3 Eric Padron, Moffitt “Enabling Precision Medicine: Clonal Reclassification of Myeloid Malignancies

  • 6/18 Peter Johnstone, Moffitt “How Cancer Populations Die

  • 3/5 Rachel Walker, USF “Predicting the future: applications across the sciences

  • 2/19 Tünde Szilágyi “Automatic brain tumor analysis and tumor growth models

  • 2/12 David Robert Grimes, Oxford “Modeling the Role of Oxygen in the Tumour Micro-environment

  • 1/29 Yi Jiang, Georgia State “Let There Be Force: Modeling Cell-Matrix Interactions In Cancer Invasion